Related Experiment Videos
Minimally invasive esophagectomy: Chinese experiences
Miao Lin1, Yaxing Shen1, Mingxiang Feng1
1Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Journal of Visualized Surgery
|October 29, 2017
Summary
Minimally invasive esophagectomy (MIE) is now standard for resectable esophageal cancer in China. This approach reduces complications compared to open surgery, with ongoing technical advancements improving outcomes.
Area of Science:
- Oncology
- Surgical Innovation
- Gastrointestinal Surgery
Background:
- Esophageal cancer is a leading cancer in China, predominantly squamous cell carcinoma.
- Minimally invasive esophagectomy (MIE) is a globally adopted standard for resectable cases.
- This paper details MIE's introduction and application in China.
Purpose of the Study:
- To introduce Minimally Invasive Esophagectomy (MIE) in China.
- To share experience and insights from a high-volume center.
- To highlight MIE's role in esophageal cancer treatment.
Main Methods:
- Over 1,300 MIE cases performed since 1994.
- Development of techniques including lateral prone position and esophageal suspension.
- Experience from a major Chinese esophageal cancer center.
Main Results:
- Reduced incidence of perioperative cardiopulmonary complications with MIE.
- Shorter operation duration due to technical innovations.
- Facilitated lymph node dissection through improved techniques.
Conclusions:
- MIE is the standard surgical procedure for resectable esophageal cancer in China.
- MIE offers lower perioperative complication rates than open surgery.
- Continuous technical improvements are enhancing MIE procedures.